These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29226631)

  • 1. Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
    Kaymakcalan H; Yarman Y; Goc N; Toy F; Meral C; Ercan-Sencicek AG; Gunel M
    Am J Med Genet A; 2018 Feb; 176(2):421-425. PubMed ID: 29226631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPT2 mutations in autosomal recessive developmental disability: extending the clinical phenotype and population prevalence estimates.
    Ouyang Q; Kavanaugh BC; Joesch-Cohen L; Dubois B; Wu Q; Schmidt M; Baytas O; Pastore SF; Harripaul R; Mishra S; Hussain A; Kim KH; Holler-Managan YF; Ayub M; Mir A; Vincent JB; Liu JS; Morrow EM
    Hum Genet; 2019 Oct; 138(10):1183-1200. PubMed ID: 31471722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPT2 mutations cause developmental encephalopathy with microcephaly and features of complicated hereditary spastic paraplegia.
    Hengel H; Keimer R; Deigendesch W; Rieß A; Marzouqa H; Zaidan J; Bauer P; Schöls L
    Clin Genet; 2018 Oct; 94(3-4):356-361. PubMed ID: 29882329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in PGAP2 gene causes developmental delay, intellectual disability, epilepsy and microcephaly in consanguineous Saudi family.
    Naseer MI; Rasool M; Jan MM; Chaudhary AG; Pushparaj PN; Abuzenadah AM; Al-Qahtani MH
    J Neurol Sci; 2016 Dec; 371():121-125. PubMed ID: 27871432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathy.
    Celis K; Shuldiner S; Haverfield EV; Cappell J; Yang R; Gong DW; Chung WK
    J Inherit Metab Dis; 2015 Sep; 38(5):941-8. PubMed ID: 25758935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense variant in GPT2 causes non-syndromic autosomal recessive intellectual disability in a consanguineous Iranian family.
    Binaafar S; Razmara E; Mahdieh N; Sahebjame H; Tavasoli AR; Garshasbi M
    Eur J Med Genet; 2020 May; 63(5):103853. PubMed ID: 31978613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in GMPPA in siblings with apparent intellectual disability, epilepsy, dysmorphism, and autonomic dysfunction.
    Gold WA; Sobreira N; Wiame E; Marbaix A; Van Schaftingen E; Franzka P; Riley LG; Worgan L; Hübner CA; Christodoulou J; Adès LC
    Am J Med Genet A; 2017 Aug; 173(8):2246-2250. PubMed ID: 28574218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNV analysis using whole exome sequencing identified biallelic CNVs of VPS13B in siblings with intellectual disability.
    Enomoto Y; Tsurusaki Y; Yokoi T; Abe-Hatano C; Ida K; Naruto T; Mitsui J; Tsuji S; Morishita S; Kurosawa K
    Eur J Med Genet; 2020 Jan; 63(1):103610. PubMed ID: 30602132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the phenotype of MED 17 mutations: Description of two new cases and review of the literature.
    Agostini A; Marchetti D; Izzi C; Cocco I; Pinelli L; Accorsi P; Iascone Maria R; Giordano L
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):687-690. PubMed ID: 30345598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features.
    Ouyang Q; Nakayama T; Baytas O; Davidson SM; Yang C; Schmidt M; Lizarraga SB; Mishra S; Ei-Quessny M; Niaz S; Gul Butt M; Imran Murtaza S; Javed A; Chaudhry HR; Vaughan DJ; Hill RS; Partlow JN; Yoo SY; Lam AT; Nasir R; Al-Saffar M; Barkovich AJ; Schwede M; Nagpal S; Rajab A; DeBerardinis RJ; Housman DE; Mochida GH; Morrow EM
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5598-607. PubMed ID: 27601654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic variants in
    Okur V; Ganapathi M; Wilson A; Chung WK
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paternal uniparental disomy of chromosome 16 resulting in homozygosity of a GPT2 mutation causes intellectual and developmental disability.
    Liu J; Chen B; Liu Y; Kong J; Zhang B; Han L; Mei D; Ma CY; Shang Q; Xie Z; Xiao M; Mei S; Zhang Y; Gao C; Li D
    Eur J Med Genet; 2022 Sep; 65(9):104554. PubMed ID: 35793769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel compound heterozygous SMG9 variants in a Chinese family with heart and brain malformation syndrome using whole exome sequencing.
    Yang Q; Qin Z; Zhang Q; Yi S; Yi S; Luo J
    BMC Med Genomics; 2022 Mar; 15(1):67. PubMed ID: 35321723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the rare compound heterozygous variants in the NEB gene in a Korean family with intellectual disability, epilepsy and early-childhood-onset generalized muscle weakness.
    Jin HS; Lee JB; Kim K; Lee KY; Choi VN; Kim JS; Jeong SY; Yim SY
    J Hum Genet; 2014 Dec; 59(12):643-7. PubMed ID: 25296583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homozygous variant disrupting the PIGH start-codon is associated with developmental delay, epilepsy, and microcephaly.
    Pagnamenta AT; Murakami Y; Anzilotti C; Titheradge H; Oates AJ; Morton J; ; Kinoshita T; Kini U; Taylor JC
    Hum Mutat; 2018 Jun; 39(6):822-826. PubMed ID: 29573052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel
    Iida A; Takano K; Takeshita E; Abe-Hatano C; Hirabayashi S; Inaba Y; Kosugi S; Kamatani Y; Momozawa Y; Kubo M; Nakagawa E; Inoue K; Goto YI
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31444167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiencies in vesicular transport mediated by TRAPPC4 are associated with severe syndromic intellectual disability.
    Van Bergen NJ; Guo Y; Al-Deri N; Lipatova Z; Stanga D; Zhao S; Murtazina R; Gyurkovska V; Pehlivan D; Mitani T; Gezdirici A; Antony J; Collins F; Willis MJH; Coban Akdemir ZH; Liu P; Punetha J; Hunter JV; Jhangiani SN; Fatih JM; Rosenfeld JA; Posey JE; Gibbs RA; Karaca E; Massey S; Ranasinghe TG; Sleiman P; Troedson C; Lupski JR; Sacher M; Segev N; Hakonarson H; Christodoulou J
    Brain; 2020 Jan; 143(1):112-130. PubMed ID: 31794024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of whole exome sequencing for syndromic retinal dystrophy diagnosis in young patients.
    Prokudin I; Li D; He S; Guo Y; Goodwin L; Wilson M; Rose L; Tian L; Chen Y; Liang J; Keating B; Xu X; Jamieson RV; Hakonarson H
    Clin Exp Ophthalmol; 2015 Mar; 43(2):132-8. PubMed ID: 25060287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genomics expands the link between erroneous cell division, primary microcephaly and intellectual disability.
    Saima ; Khan A; Ali S; Jiang J; Miao Z; Kamil A; Khan SN; Arold ST
    Neurogenetics; 2024 Jul; 25(3):179-191. PubMed ID: 38795246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.